4//SEC Filing
Pine Michael Craig 4
Accession 0001562180-23-004580
CIK 0001314102other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 5:14 PM ET
Size
8.0 KB
Accession
0001562180-23-004580
Insider Transaction Report
Form 4
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
Transactions
- Award
Restricted Stock Units
2023-05-25+7,500→ 7,500 totalExercise: $0.00→ Common Stock (7,500 underlying) - Award
Stock Option (Right to Buy)
2023-05-25+15,000→ 15,000 totalExercise: $5.93Exp: 2033-05-24→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The option to purchase will vest and become exercisable as follows: 25% at May 25th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years.
- [F2]The restricted stock units will vest in three ratable annual installments beginning May 25, 2024.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001904458
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 5:14 PM ET
- Size
- 8.0 KB